Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical ...

While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...

In a new era of Alzheimer’s disease research, the emergence of blockbuster therapies like Eli Lilly’s Kisunla (donanemab) and ...

Island Pharmaceuticals Ltd (AU:ILA) has released an update. Island Pharmaceuticals Ltd has announced significant progress in its ISLA-101 Phase ...

Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...

Clinical Trial Imaging Services Market, valued at USD 1.31 billion in 2023, is expected to grow at a compound annual growth rate of 5.4 ...

Anti-amyloid antibodies lecanemab and donanemab are in clinical use now, but that does not mean research on them has stopped. At the Clinical Trials on Alzheimer’s Disease conference, held October ...

The U.S. Food and Drug Administration (FDA) recently held a Patient Engagement Advisory Committee meeting focused on clinical trial informed ...

Clinical data from the RESET-Myositis™ and RESET-SLE™ trials, along with initial clinical data from the RESET-SSc™ trial, to be presented this ...

In the increasingly complex healthcare realm, a regular flow of drug introductions offers potential benefits to millions of ...

While these sites are important for clinical research, they make patient recruitment challenging. Many participants are ...

Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...